Corrigendum to ‘Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study’. EBioMedicine 2024;108: 105320
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-09-01
|
| Series: | EBioMedicine |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396425003184 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849226950046908416 |
|---|---|
| author | Avi Kenny Janine van Duijn One Dintwe Jack Heptinstall Randy Burnham Sheetal Sawant Lu Zhang Dieter Mielke Sharon Khuzwayo Faatima Laher Omar Sherry Stanfield-Oakley Taylor Keyes Brooke Dunn Derrick Goodman Youyi Fong David Benkeser Rodger Zou John Hural Ollivier Hyrien Michal Juraska Alex Luedtke Lars van der Laan Elena E. Giorgi Craig Magaret Lindsay N. Carpp Laura Pattacini Tom van de Kerkhof Bette Korber Wouter Willems Leigh H. Fisher Hanneke Schuitemaker Edith Swann James G. Kublin Maria G. Pau Susan Buchbinder Frank Tomaka Steven Nijs Ludo Lavreys Huub C. Gelderblom Lawrence Corey Kathryn Mngadi Glenda E. Gray Erica Borducchi Jenny Hendriks Kelly E. Seaton Susan Zolla-Pazner Dan H. Barouch Guido Ferrari Stephen C. De Rosa M Juliana McElrath Erica Andersen-Nissen Daniel J. Stieh Georgia D. Tomaras Peter B. Gilbert Jon Allagappen Jessica Andriesen Alison Ayres Saman Baral Linda-Gail Bekker Asiphe Besethi Caroline Borremans Esmee Braams Caroline Brackett William Brumskine Roma Chilengi Rachel Choi Thozama Dubula Jaiden Seongmi Dumas Brooke Dunn Radhika Etikala Zelda Euler Sarah Everett Nigel Garrett Huub Gelderblom Katherine Gill Kevin Gillespie Dimitri Goedhart Erik Goosmann Shannon Grant Ellie Hands Barton Haynes Bronwill Herringer Zaheer Hoosain Mina Hosseinipour Portia Hunidzarira Julia Hutter Mubiana Inambao Craig Innes Taylor Keyes William Kilembe Philippus Kotze Sheena Kotze Fatima Laher Imre Laszlo Erica Lazarus Hua-Xin Liao Yong Lin Helen Lu Judith Lucas Mookho Malahleha Tara McNair Peter Meerts Zinhle Mgaga Mahlodi Montlha Boitumelo Mosito Andrew Moultrie Sarah Mudrak Valérie Oriol-Mathieu Marcella Sarzotti-Kelsoe Matson Tso Mathebula Mitch Matoga Rachael McClennen Pamela Mda Peter Meerts Vimla Naicker Logashvari Naidoo Cindy-Ann Okkers Saleha Omarjee Hella Pasmans Tricia Philip Abraham Pinter Annah Pitsi Ornelia Ramos April Randhawa Sanne Roels Shamiska Rohith Lucy Rutten Jerald Sadoff Gabriela Salinas Yvonne Salzgeber Lorenz Scheppler Katharine Schwedhelm Nicolette Schuller Angelina Sharak Sherry Stanfield-Oakley Carrie Sopher Terence Tafatatha Simbarashe G. Takuva Chan Tang An Vandebosch Edna Viegas Valentin Voillet Frank Wegmann Mo Weijtens Stephany Wilcox Anthony Williams Chenchen Yu Pei-Chun Yu Olive Yuan Xuehan Zhang |
| author_facet | Avi Kenny Janine van Duijn One Dintwe Jack Heptinstall Randy Burnham Sheetal Sawant Lu Zhang Dieter Mielke Sharon Khuzwayo Faatima Laher Omar Sherry Stanfield-Oakley Taylor Keyes Brooke Dunn Derrick Goodman Youyi Fong David Benkeser Rodger Zou John Hural Ollivier Hyrien Michal Juraska Alex Luedtke Lars van der Laan Elena E. Giorgi Craig Magaret Lindsay N. Carpp Laura Pattacini Tom van de Kerkhof Bette Korber Wouter Willems Leigh H. Fisher Hanneke Schuitemaker Edith Swann James G. Kublin Maria G. Pau Susan Buchbinder Frank Tomaka Steven Nijs Ludo Lavreys Huub C. Gelderblom Lawrence Corey Kathryn Mngadi Glenda E. Gray Erica Borducchi Jenny Hendriks Kelly E. Seaton Susan Zolla-Pazner Dan H. Barouch Guido Ferrari Stephen C. De Rosa M Juliana McElrath Erica Andersen-Nissen Daniel J. Stieh Georgia D. Tomaras Peter B. Gilbert Jon Allagappen Jessica Andriesen Alison Ayres Saman Baral Linda-Gail Bekker Asiphe Besethi Caroline Borremans Esmee Braams Caroline Brackett William Brumskine Roma Chilengi Rachel Choi Thozama Dubula Jaiden Seongmi Dumas Brooke Dunn Radhika Etikala Zelda Euler Sarah Everett Nigel Garrett Huub Gelderblom Katherine Gill Kevin Gillespie Dimitri Goedhart Erik Goosmann Shannon Grant Ellie Hands Barton Haynes Bronwill Herringer Zaheer Hoosain Mina Hosseinipour Portia Hunidzarira Julia Hutter Mubiana Inambao Craig Innes Taylor Keyes William Kilembe Philippus Kotze Sheena Kotze Fatima Laher Imre Laszlo Erica Lazarus Hua-Xin Liao Yong Lin Helen Lu Judith Lucas Mookho Malahleha Tara McNair Peter Meerts Zinhle Mgaga Mahlodi Montlha Boitumelo Mosito Andrew Moultrie Sarah Mudrak Valérie Oriol-Mathieu Marcella Sarzotti-Kelsoe Matson Tso Mathebula Mitch Matoga Rachael McClennen Pamela Mda Peter Meerts Vimla Naicker Logashvari Naidoo Cindy-Ann Okkers Saleha Omarjee Hella Pasmans Tricia Philip Abraham Pinter Annah Pitsi Ornelia Ramos April Randhawa Sanne Roels Shamiska Rohith Lucy Rutten Jerald Sadoff Gabriela Salinas Yvonne Salzgeber Lorenz Scheppler Katharine Schwedhelm Nicolette Schuller Angelina Sharak Sherry Stanfield-Oakley Carrie Sopher Terence Tafatatha Simbarashe G. Takuva Chan Tang An Vandebosch Edna Viegas Valentin Voillet Frank Wegmann Mo Weijtens Stephany Wilcox Anthony Williams Chenchen Yu Pei-Chun Yu Olive Yuan Xuehan Zhang |
| author_sort | Avi Kenny |
| collection | DOAJ |
| format | Article |
| id | doaj-art-a00f2a5a731e4dc8a0e717eb051a5939 |
| institution | Kabale University |
| issn | 2352-3964 |
| language | English |
| publishDate | 2025-09-01 |
| publisher | Elsevier |
| record_format | Article |
| series | EBioMedicine |
| spelling | doaj-art-a00f2a5a731e4dc8a0e717eb051a59392025-08-24T05:13:24ZengElsevierEBioMedicine2352-39642025-09-0111910587410.1016/j.ebiom.2025.105874Corrigendum to ‘Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study’. EBioMedicine 2024;108: 105320Avi Kenny0Janine van Duijn1One Dintwe2Jack Heptinstall3Randy Burnham4Sheetal Sawant5Lu Zhang6Dieter Mielke7Sharon Khuzwayo8Faatima Laher Omar9Sherry Stanfield-Oakley10Taylor Keyes11Brooke Dunn12Derrick Goodman13Youyi Fong14David Benkeser15Rodger Zou16John Hural17Ollivier Hyrien18Michal Juraska19Alex Luedtke20Lars van der Laan21Elena E. Giorgi22Craig Magaret23Lindsay N. Carpp24Laura Pattacini25Tom van de Kerkhof26Bette Korber27Wouter Willems28Leigh H. Fisher29Hanneke Schuitemaker30Edith Swann31James G. Kublin32Maria G. Pau33Susan Buchbinder34Frank Tomaka35Steven Nijs36Ludo Lavreys37Huub C. Gelderblom38Lawrence Corey39Kathryn Mngadi40Glenda E. Gray41Erica Borducchi42Jenny Hendriks43Kelly E. Seaton44Susan Zolla-Pazner45Dan H. Barouch46Guido Ferrari47Stephen C. De Rosa48M Juliana McElrath49Erica Andersen-Nissen50Daniel J. Stieh51Georgia D. Tomaras52Peter B. Gilbert53Jon AllagappenJessica AndriesenAlison AyresSaman BaralLinda-Gail BekkerAsiphe BesethiCaroline BorremansEsmee BraamsCaroline BrackettWilliam BrumskineRoma ChilengiRachel ChoiThozama DubulaJaiden Seongmi DumasBrooke DunnRadhika EtikalaZelda EulerSarah EverettNigel GarrettHuub GelderblomKatherine GillKevin GillespieDimitri GoedhartErik GoosmannShannon GrantEllie HandsBarton HaynesBronwill HerringerZaheer HoosainMina HosseinipourPortia HunidzariraJulia HutterMubiana InambaoCraig InnesTaylor KeyesWilliam KilembePhilippus KotzeSheena KotzeFatima LaherImre LaszloErica LazarusHua-Xin LiaoYong LinHelen LuJudith LucasMookho MalahlehaTara McNairPeter MeertsZinhle MgagaMahlodi MontlhaBoitumelo MositoAndrew MoultrieSarah MudrakValérie Oriol-MathieuMarcella Sarzotti-KelsoeMatson Tso MathebulaMitch MatogaRachael McClennenPamela MdaPeter MeertsVimla NaickerLogashvari NaidooCindy-Ann OkkersSaleha OmarjeeHella PasmansTricia PhilipAbraham PinterAnnah PitsiOrnelia RamosApril RandhawaSanne RoelsShamiska RohithLucy RuttenJerald SadoffGabriela SalinasYvonne SalzgeberLorenz SchepplerKatharine SchwedhelmNicolette SchullerAngelina SharakSherry Stanfield-OakleyCarrie SopherTerence TafatathaSimbarashe G. TakuvaChan TangAn VandeboschEdna ViegasValentin VoilletFrank WegmannMo WeijtensStephany WilcoxAnthony WilliamsChenchen YuPei-Chun YuOlive YuanXuehan ZhangDepartment of Biostatistics, University of Washington, Seattle, WA, USAJanssen Vaccines & Prevention BV, Leiden, the NetherlandsVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Cape Town HVTN Immunology Laboratory, Hutchinson Centre Research Institute of South Africa, Cape Town, South AfricaCenter for Human Systems Immunology, Department of Surgery, Duke University, Durham, NC, USA; Duke Human Vaccine Institute, Durham, NC, USAVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USACenter for Human Systems Immunology, Department of Surgery, Duke University, Durham, NC, USA; Duke Human Vaccine Institute, Durham, NC, USACenter for Human Systems Immunology, Department of Surgery, Duke University, Durham, NC, USA; Duke Human Vaccine Institute, Durham, NC, USACenter for Human Systems Immunology, Department of Surgery, Duke University, Durham, NC, USACape Town HVTN Immunology Laboratory, Hutchinson Centre Research Institute of South Africa, Cape Town, South AfricaCape Town HVTN Immunology Laboratory, Hutchinson Centre Research Institute of South Africa, Cape Town, South AfricaCenter for Human Systems Immunology, Department of Surgery, Duke University, Durham, NC, USACenter for Human Systems Immunology, Department of Surgery, Duke University, Durham, NC, USACenter for Human Systems Immunology, Department of Surgery, Duke University, Durham, NC, USACenter for Human Systems Immunology, Department of Surgery, Duke University, Durham, NC, USA; Duke Human Vaccine Institute, Durham, NC, USAVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USADepartment of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA, USAVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USAVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USAVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USAVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USADepartment of Statistics, University of Washington, Seattle, WA, USAVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Statistics, University of Washington, Seattle, WA, USAVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USAVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USAVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USAJanssen Vaccines & Prevention BV, Leiden, the NetherlandsJanssen Vaccines & Prevention BV, Leiden, the NetherlandsLos Alamos National Laboratory, Los Alamos, NM, USA; New Mexico Consortium, Los Alamos, NM, USAJanssen Research & Development BE, Beerse, BelgiumVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USAJanssen Vaccines & Prevention BV, Leiden, the NetherlandsDivision of AIDS, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USAVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USAJanssen Infectious Diseases BV, Beerse, BelgiumSan Francisco Department of Public Health, San Francisco, CA, USAJanssen Research & Development, LLC, Titusville, NJ, USAJanssen Infectious Diseases BV, Beerse, BelgiumJanssen Infectious Diseases BV, Beerse, BelgiumVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USAVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA; Department of Medicine, University of Washington, Seattle, WA, 98195, USAThe Aurum Institute, Johannesburg, South AfricaSouth African Medical Research Council, Cape Town, South AfricaCenter for Virology & Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USAJanssen Vaccines & Prevention BV, Leiden, the NetherlandsCenter for Human Systems Immunology, Department of Surgery, Duke University, Durham, NC, USA; Duke Human Vaccine Institute, Durham, NC, USAIcahn School of Medicine at Mount Sinai, New York, NY, USACenter for Virology & Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge, MA, USACenter for Human Systems Immunology, Department of Surgery, Duke University, Durham, NC, USA; Duke Human Vaccine Institute, Durham, NC, USAVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USAVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USAVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Cape Town HVTN Immunology Laboratory, Hutchinson Centre Research Institute of South Africa, Cape Town, South AfricaJanssen Vaccines & Prevention BV, Leiden, the NetherlandsCenter for Human Systems Immunology, Department of Surgery, Duke University, Durham, NC, USA; Duke Human Vaccine Institute, Durham, NC, USA; Department of Integrative Immunobiology, Duke University, Durham, NC, USA; Corresponding author. Duke Center for Human Systems Immunology, Departments of Surgery, Immunology, Molecular Genetics and Microbiology, Duke University, Room 4079 MSRBII, 2 Genome Ct, Durham, NC, 27710, USA.Department of Biostatistics, University of Washington, Seattle, WA, USA; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Corresponding author. Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, 1100 Fairview Avenue North, M2-C200, Seattle, WA, 98109, USA.http://www.sciencedirect.com/science/article/pii/S2352396425003184 |
| spellingShingle | Avi Kenny Janine van Duijn One Dintwe Jack Heptinstall Randy Burnham Sheetal Sawant Lu Zhang Dieter Mielke Sharon Khuzwayo Faatima Laher Omar Sherry Stanfield-Oakley Taylor Keyes Brooke Dunn Derrick Goodman Youyi Fong David Benkeser Rodger Zou John Hural Ollivier Hyrien Michal Juraska Alex Luedtke Lars van der Laan Elena E. Giorgi Craig Magaret Lindsay N. Carpp Laura Pattacini Tom van de Kerkhof Bette Korber Wouter Willems Leigh H. Fisher Hanneke Schuitemaker Edith Swann James G. Kublin Maria G. Pau Susan Buchbinder Frank Tomaka Steven Nijs Ludo Lavreys Huub C. Gelderblom Lawrence Corey Kathryn Mngadi Glenda E. Gray Erica Borducchi Jenny Hendriks Kelly E. Seaton Susan Zolla-Pazner Dan H. Barouch Guido Ferrari Stephen C. De Rosa M Juliana McElrath Erica Andersen-Nissen Daniel J. Stieh Georgia D. Tomaras Peter B. Gilbert Jon Allagappen Jessica Andriesen Alison Ayres Saman Baral Linda-Gail Bekker Asiphe Besethi Caroline Borremans Esmee Braams Caroline Brackett William Brumskine Roma Chilengi Rachel Choi Thozama Dubula Jaiden Seongmi Dumas Brooke Dunn Radhika Etikala Zelda Euler Sarah Everett Nigel Garrett Huub Gelderblom Katherine Gill Kevin Gillespie Dimitri Goedhart Erik Goosmann Shannon Grant Ellie Hands Barton Haynes Bronwill Herringer Zaheer Hoosain Mina Hosseinipour Portia Hunidzarira Julia Hutter Mubiana Inambao Craig Innes Taylor Keyes William Kilembe Philippus Kotze Sheena Kotze Fatima Laher Imre Laszlo Erica Lazarus Hua-Xin Liao Yong Lin Helen Lu Judith Lucas Mookho Malahleha Tara McNair Peter Meerts Zinhle Mgaga Mahlodi Montlha Boitumelo Mosito Andrew Moultrie Sarah Mudrak Valérie Oriol-Mathieu Marcella Sarzotti-Kelsoe Matson Tso Mathebula Mitch Matoga Rachael McClennen Pamela Mda Peter Meerts Vimla Naicker Logashvari Naidoo Cindy-Ann Okkers Saleha Omarjee Hella Pasmans Tricia Philip Abraham Pinter Annah Pitsi Ornelia Ramos April Randhawa Sanne Roels Shamiska Rohith Lucy Rutten Jerald Sadoff Gabriela Salinas Yvonne Salzgeber Lorenz Scheppler Katharine Schwedhelm Nicolette Schuller Angelina Sharak Sherry Stanfield-Oakley Carrie Sopher Terence Tafatatha Simbarashe G. Takuva Chan Tang An Vandebosch Edna Viegas Valentin Voillet Frank Wegmann Mo Weijtens Stephany Wilcox Anthony Williams Chenchen Yu Pei-Chun Yu Olive Yuan Xuehan Zhang Corrigendum to ‘Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study’. EBioMedicine 2024;108: 105320 EBioMedicine |
| title | Corrigendum to ‘Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study’. EBioMedicine 2024;108: 105320 |
| title_full | Corrigendum to ‘Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study’. EBioMedicine 2024;108: 105320 |
| title_fullStr | Corrigendum to ‘Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study’. EBioMedicine 2024;108: 105320 |
| title_full_unstemmed | Corrigendum to ‘Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study’. EBioMedicine 2024;108: 105320 |
| title_short | Corrigendum to ‘Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study’. EBioMedicine 2024;108: 105320 |
| title_sort | corrigendum to immune correlates analysis of the imbokodo hvtn 705 hpx2008 efficacy trial of a mosaic hiv 1 vaccine regimen evaluated in southern african people assigned female sex at birth a two phase case control study ebiomedicine 2024 108 105320 |
| url | http://www.sciencedirect.com/science/article/pii/S2352396425003184 |
| work_keys_str_mv | AT avikenny corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT janinevanduijn corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT onedintwe corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT jackheptinstall corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT randyburnham corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT sheetalsawant corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT luzhang corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT dietermielke corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT sharonkhuzwayo corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT faatimalaheromar corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT sherrystanfieldoakley corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT taylorkeyes corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT brookedunn corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT derrickgoodman corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT youyifong corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT davidbenkeser corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT rodgerzou corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT johnhural corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT ollivierhyrien corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT michaljuraska corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT alexluedtke corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT larsvanderlaan corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT elenaegiorgi corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT craigmagaret corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT lindsayncarpp corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT laurapattacini corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT tomvandekerkhof corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT bettekorber corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT wouterwillems corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT leighhfisher corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT hannekeschuitemaker corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT edithswann corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT jamesgkublin corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT mariagpau corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT susanbuchbinder corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT franktomaka corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT stevennijs corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT ludolavreys corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT huubcgelderblom corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT lawrencecorey corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT kathrynmngadi corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT glendaegray corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT ericaborducchi corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT jennyhendriks corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT kellyeseaton corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT susanzollapazner corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT danhbarouch corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT guidoferrari corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT stephencderosa corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT mjulianamcelrath corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT ericaandersennissen corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT danieljstieh corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT georgiadtomaras corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT peterbgilbert corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT jonallagappen corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT jessicaandriesen corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT alisonayres corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT samanbaral corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT lindagailbekker corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT asiphebesethi corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT carolineborremans corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT esmeebraams corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT carolinebrackett corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT williambrumskine corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT romachilengi corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT rachelchoi corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT thozamadubula corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT jaidenseongmidumas corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT brookedunn corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT radhikaetikala corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT zeldaeuler corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT saraheverett corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT nigelgarrett corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT huubgelderblom corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT katherinegill corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT kevingillespie corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT dimitrigoedhart corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT erikgoosmann corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT shannongrant corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT elliehands corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT bartonhaynes corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT bronwillherringer corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT zaheerhoosain corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT minahosseinipour corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT portiahunidzarira corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT juliahutter corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT mubianainambao corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT craiginnes corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT taylorkeyes corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT williamkilembe corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT philippuskotze corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT sheenakotze corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT fatimalaher corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT imrelaszlo corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT ericalazarus corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT huaxinliao corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT yonglin corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT helenlu corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT judithlucas corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT mookhomalahleha corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT taramcnair corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT petermeerts corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT zinhlemgaga corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT mahlodimontlha corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT boitumelomosito corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT andrewmoultrie corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT sarahmudrak corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT valerieoriolmathieu corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT marcellasarzottikelsoe corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT matsontsomathebula corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT mitchmatoga corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT rachaelmcclennen corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT pamelamda corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT petermeerts corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT vimlanaicker corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT logashvarinaidoo corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT cindyannokkers corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT salehaomarjee corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT hellapasmans corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT triciaphilip corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT abrahampinter corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT annahpitsi corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT orneliaramos corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT aprilrandhawa corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT sanneroels corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT shamiskarohith corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT lucyrutten corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT jeraldsadoff corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT gabrielasalinas corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT yvonnesalzgeber corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT lorenzscheppler corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT katharineschwedhelm corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT nicoletteschuller corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT angelinasharak corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT sherrystanfieldoakley corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT carriesopher corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT terencetafatatha corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT simbarashegtakuva corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT chantang corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT anvandebosch corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT ednaviegas corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT valentinvoillet corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT frankwegmann corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT moweijtens corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT stephanywilcox corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT anthonywilliams corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT chenchenyu corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT peichunyu corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT oliveyuan corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 AT xuehanzhang corrigendumtoimmunecorrelatesanalysisoftheimbokodohvtn705hpx2008efficacytrialofamosaichiv1vaccineregimenevaluatedinsouthernafricanpeopleassignedfemalesexatbirthatwophasecasecontrolstudyebiomedicine2024108105320 |